| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CMMI.1645 |
| P698 | PubMed publication ID | 26010530 |
| P50 | author | Odd Helge Gilja | Q56655099 |
| Natalia Arteaga-Marrero | Q89977178 | ||
| Rolf K Reed | Q43605516 | ||
| P2093 | author name string | D R Olsen | |
| N Lutay | |||
| L Svensson | |||
| C B Rygh | |||
| D Roehrich | |||
| J F Mainou-Gomez | |||
| J Heggdal | |||
| K Nylund | |||
| P Matulaniec | |||
| P2860 | cites work | Parotid perfusion in nasopharyngeal carcinoma patients in early-to-intermediate stage after low-dose intensity-modulated radiotherapy: evaluated by fat-saturated dynamic contrast-enhanced magnetic resonance imaging | Q48957316 |
| Correlation between estimates of tumor perfusion from microbubble contrast-enhanced sonography and dynamic contrast-enhanced magnetic resonance imaging | Q51240087 | ||
| Reliability of pharmacokinetic parameters: small vs. medium-sized contrast agents | Q53058987 | ||
| Interactive visual analysis of contrast-enhanced ultrasound data based on small neighborhood statistics | Q56135863 | ||
| Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent | Q73966101 | ||
| Assessment of tumor microcirculation with dynamic contrast-enhanced MRI in patients with esophageal cancer: initial experience | Q81340341 | ||
| DCEMRI monitoring of canine tumors during fractionated radiotherapy | Q81622193 | ||
| Openings between defective endothelial cells explain tumor vessel leakiness | Q24681507 | ||
| Tumor Endothelial Cells | Q26995733 | ||
| NG2 expression regulates vascular morphology and function in human brain tumours | Q28279236 | ||
| Parametric imaging for characterizing focal liver lesions in contrast-enhanced ultrasound | Q28297370 | ||
| Primary Xenografts of Human Prostate Tissue as a Model to Study Angiogenesis Induced by Reactive Stroma | Q28732327 | ||
| In vitro acoustic characterization of three phospholipid ultrasound contrast agents from 12 to 43 MHz. | Q30442488 | ||
| Contrast-enhanced and targeted ultrasound | Q30477621 | ||
| Tumor vessel compression hinders perfusion of ultrasonographic contrast agents. | Q30501504 | ||
| Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers | Q33235069 | ||
| Atrial natriuretic peptide modulation of albumin clearance and contrast agent permeability in mouse skeletal muscle and skin: role in regulation of plasma volume | Q33516914 | ||
| Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. | Q33744660 | ||
| Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability | Q34083937 | ||
| Longitudinal magnetic resonance imaging-based assessment of vascular changes and radiation response in androgen-sensitive prostate carcinoma xenografts under androgen-exposed and androgen-deprived conditions | Q34177229 | ||
| Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: assumptions, limitations, and potential implications for clinical use. | Q34589049 | ||
| Vascular permeability, vascular hyperpermeability and angiogenesis | Q34753662 | ||
| Nano-sized MRI contrast agents with dendrimer cores | Q36313785 | ||
| Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker | Q36531396 | ||
| Microbubble ultrasound contrast agents: an update | Q36757394 | ||
| Multiple significance tests: the Bonferroni method | Q36901984 | ||
| Perfusion measurement using DCE-MRI: implications for hyperthermia | Q37063506 | ||
| Coregistration of ultrasonography and magnetic resonance imaging with a preliminary investigation of the spatial colocalization of vascular endothelial growth factor receptor 2 expression and tumor perfusion in a murine tumor model | Q37335861 | ||
| Sonoporation: mechanistic insights and ongoing challenges for gene transfer | Q38097180 | ||
| Neoangiogenesis in prostate cancer | Q38193434 | ||
| MCT-1 oncogene contributes to increased in vivo tumorigenicity of MCF7 cells by promotion of angiogenesis and inhibition of apoptosis | Q40345181 | ||
| The Principal of Dynamic Contrast Enhanced MRI, the Method of Pharmacokinetic Analysis, and Its Application in the Head and Neck Region | Q41643320 | ||
| Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. | Q42629066 | ||
| Ultrasound perfusion analysis combining bolus-tracking and burst-replenishment | Q43720655 | ||
| Perfusion quantification using dynamic contrast-enhanced ultrasound: the impact of dynamic range and gain on time-intensity curves | Q44100650 | ||
| Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome | Q44429198 | ||
| Modified brix model analysis of bone perfusion in subjects of varying bone mineral density | Q44488698 | ||
| Assessment of quantitative perfusion parameters by dynamic contrast-enhanced sonography using a deconvolution method: an in vitro and in vivo study | Q47990468 | ||
| P433 | issue | 6 | |
| P921 | main subject | xenograft | Q64148587 |
| tumour xenograft | Q112042499 | ||
| P304 | page(s) | 428-437 | |
| P577 | publication date | 2015-05-26 | |
| P1433 | published in | Contrast Media & Molecular Imaging | Q2995750 |
| P1476 | title | Multimodal approach to assess tumour vasculature and potential treatment effect with DCE-US and DCE-MRI quantification in CWR22 prostate tumour xenografts | |
| P478 | volume | 10 |
| Q49622958 | Dynamics of angiogenesis and cellularity in rabbit VX2 tumors using contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging |
| Q47148716 | Experimental imaging in orthotopic renal cell carcinoma xenograft models: comparative evaluation of high-resolution 3D ultrasonography, in-vivo micro-CT and 9.4T MRI. |
| Q30395717 | Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US. |
Search more.